Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Addex Therapeutics Ltd ADR
(NQ:
ADXN
)
7.650
-0.250 (-3.16%)
Streaming Delayed Price
Updated: 3:50 PM EDT, Aug 23, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Addex Therapeutics Ltd ADR
< Previous
1
2
3
4
5
6
Next >
Dow Jumps Over 100 Points; Crude Oil Down 7%
June 17, 2022
U.S. stocks traded higher toward the end of trading, with the Dow Jones gaining more than 100 points on Friday.
Via
Benzinga
Dow Jones Turns Lower; Revlon Shares Jump
June 17, 2022
U.S. stocks pared gains midway through trading, with the Dow Jones dropping around 100 points on Friday.
Via
Benzinga
33 Stocks Moving In Friday's Mid-Day Session
June 17, 2022
Gainers Revlon, Inc. (NYSE: REV) gained 81.5% to $3.54 following a report suggesting Reliance Industries is considering buying out the company, which recently filed for bankruptcy.
Via
Benzinga
The Daily Biotech Pulse: Addex Terminates Parkinson's Study, Expanded Use Of Rhythm's Obesity Drug, FDA Approval For AbbVie's Skyrizi In Crohn's Disease
June 17, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours:
Via
Benzinga
Addex Stops Parkinson's-Associated Dyskinesia Trial - Read Here Why
June 17, 2022
Via
Benzinga
Earnings Scheduled For March 10, 2022
March 10, 2022
Companies Reporting Before The Bell • Despegar.com (NYSE:DESP) is expected to report quarterly loss at $0.08 per share on revenue of $110.93 million. • ProShares...
Via
Benzinga
Why Shares Of Addex Therapeutics Are Falling Today
June 17, 2022
Shares of small-cap penny stock Addex Therapeutics Ltd. (NASDAQ: ADXN) are trading lower after the company terminated its Phase 2b/3 study of Dipraglurant for dyskinesia associated with Parkinson's...
Via
Benzinga
U.S. Markets Open Higher; Dow Rises Around 200 Points
June 17, 2022
U.S. stocks traded higher this morning, with the Dow Jones gaining around 200 points on Friday.
Via
Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
June 17, 2022
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
June 17, 2022
Good morning! We're entering the final day of trading for the week with a look at the biggest pre-market stock movers for Friday!
Via
InvestorPlace
21 Stocks Moving in Friday's Pre-Market Session
June 17, 2022
Gainers Athersys, Inc. (NASDAQ: ATHX) rose 48.5% to $0.4755 in pre-market trading after dropping more than 12% on Thursday.
Via
Benzinga
88 Biggest Movers From Yesterday
May 26, 2022
Gainers The Very Good Food Company Inc. (NASDAQ: VGFC) shares jumped 118.2% to close at $0.2950 on Wednesday as the company announced it increased retail distribution across Canada with Loblaw...
Via
Benzinga
50 Stocks Moving In Wednesday's Mid-Day Session
May 25, 2022
Gainers The Very Good Food Company Inc. (NASDAQ: VGFC) gained 178.3% to $0.3762 as the company announced it increased retail distribution across Canada with Loblaw Companies.
Via
Benzinga
21 Stocks Moving in Wednesday's Pre-Market Session
May 25, 2022
Gainers The Singing Machine Company, Inc. (NASDAQ: MICS) shares rose 47.3% to $4.05 in pre-market trading.
Via
Benzinga
71 Biggest Movers From Yesterday
April 27, 2022
Gainers Evoke Pharma, Inc. (NASDAQ: EVOK) shares jumped 118.5% to close at $0.86 on Tuesday. The FDA granted new drug product exclusivity to Evoke Pharma's Gimoti (...
Via
Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
April 18, 2022
Gainers Natus Medical (NASDAQ:NTUS) shares rose 28.8% to $33.55 during Monday's regular session. The current volume of 3.0 million shares is 2073.2% of Natus Medical...
Via
Benzinga
68 Biggest Movers From Yesterday
April 19, 2022
Gainers Casa Systems, Inc. (NASDAQ: CASA) shares surged 82.5% to close at $7.10 on Monday after the company announced a multi-year contract with Verizon to provide 5G core...
Via
Benzinga
Addex Expands Pipeline With Selective M4 PAM Program For Schizophrenia & Other Psychotic Disorders
April 06, 2022
Addex Therapeutics (NASDAQ: ADXN) has moved a selective and potent M4 muscarinic receptor positive allosteric modulator (PAM) program into lead optimization, with a
Via
Benzinga
10 Biggest Price Target Changes For Friday
February 11, 2022
SVB Leerink cut Illumina, Inc. (NASDAQ: ILMN) price target from $430 to $400. Illumina shares fell 0.7% to $355.70 in pre-market trading.
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
January 26, 2022
Gainers Vaccinex (NASDAQ:VCNX) shares moved upwards by 30.4% to $1.33 during Wednesday's pre-market session. The market value of their outstanding shares is at $40.9...
Via
Benzinga
Addex Therapeutics Stock Falls After $10M Capital Raise Via Equity
December 17, 2021
Addex Therapeutics Ltd (NASDAQ: ADXN) will sell 3.75 million shares to Armistice Capital in the form of 625,367 American Depositary Shares (ADSs) at $6....
Via
Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
December 17, 2021
Gainers Genfit (NASDAQ:GNFT) stock moved upwards by 38.55% to $4.6 during Friday's pre-market session. The market value of their outstanding shares is at $210.4...
Via
Benzinga
The Daily Biotech Pulse: NRx Stitches COVID-19 Drug Partnership, Protara Gets Nod For Starting Bladder Cancer Study, IGM Moves Beyond Oncology
October 12, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Oct. 11) AstraZeneca Plc (NASDAQ:...
Via
Benzinga
Exposures
COVID-19
The Daily Biotech Pulse: AbbVie's Migraine Drug OK'd By FDA, Amicus Spins Off Gene Therapy Business, Geovax In-Licenses Cancer Drug
September 29, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Click here for accessing Benzinga's FDA Calendar Scaling The Peaks (Biotech Stocks...
Via
Benzinga
Exposures
Product Safety
Addex Therapeutics, CMTA Join Forces To Develop Potential Treatment For Rare Neurological Disorder
September 22, 2021
The Charcot–Marie–Tooth Association (CMTA), a philanthropic funder of CMT research worldwide, and Addex Therapeutics Ltd (NASDAQ: ADXN) have...
Via
Benzinga
45 Stocks Moving In Tuesday's Mid-Day Session
September 07, 2021
Gainers IronNet, Inc. (NYSE: IRNT) shares jumped 50.4% to $25.06 after jumping over 23% on Friday. Mechel PAO (NYSE: MTL) shares jumped 32.6% to $4.2443. The company recently...
Via
Benzinga
23 Stocks Moving in Tuesday's Pre-Market Session
September 07, 2021
Gainers IronNet, Inc. (NYSE: IRNT) rose 89.7% to $31.61 in pre-market trading after jumping over 23% on Friday. Mechel PAO (NYSE: MTL) shares rose 36.6% to $4.37 in pre-market...
Via
Benzinga
Addex Therapeutics Starts Mid-Stage Study For Dipraglurant In Parkinson's Associated Dyskinesia
June 29, 2021
Addex Therapeutics Ltd (NASDAQ: ADXN) has started patient screening for its Phase 2b/3 study evaluating dipraglurant for dyskinesia associated with Parkinson's...
Via
Benzinga
Earnings Scheduled For August 2, 2021
August 02, 2021
Companies Reporting Before The Bell • HSBC Holdings (NYSE:HSBC) is estimated to report earnings for its second quarter. • Addex Therapeutics (NASDAQ:ADXN) is...
Via
Benzinga
The Daily Biotech Pulse: COVID Disappointments For Altimmune And Angion, Brickell Jumps On Hyperhidrosis Study Updates, 2 IPOs
June 30, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 29) 10x Genomics, Inc. (NASDAQ...
Via
Benzinga
< Previous
1
2
3
4
5
6
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.